Pacific Biosciences Of California Inc (PACB) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Pacific Biosciences Of California Inc   (NASDAQ: PACB)
 

Pacific Biosciences Of California Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Pacific Biosciences Of California Inc 's inventory turnover ratio sequentially decreased to 1.89 in the second quarter 2026, unsurprisingly, as the Pacific Biosciences Of California Inc markets continue to deteriorate, and PACB's faces growing challenges to bring down its inventories. Pacific Biosciences Of California Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 193 days, from 189 days, in the Mar 31 2026 quarter.

Within Healthcare sector 216 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1381 in the first quarter 2026, to 1597.

PACB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Pacific Biosciences Of California Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PACB Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 13.46 % -5.53 % -16.12 % -19.14 % -21.51 %
Y / Y Cost of Sales Growth 5.48 % -36.84 % -3.33 % -24.14 % -16.67 %
Inventory Turnover Ratio (TTM) 1.89 1.93 2.17 2.09 2.1
PACB's Total Ranking # 1597 # 1381 # 1059 # 1290 # 1185
Average inventory processing period 193 189 168 174 174
Seq. Inventory Growth 19.72 % 3.52 % -7.28 % -1.27 % -0.31 %
Seq. Cost of Sales Growth 9.87 % -17.24 % 31.82 % -12 % -34.21 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 12
Healthcare Sector # 217
Overall Market # 1597

Inventory Turnover Ratio Statistics
High Average Low
4.09 2.71 1.66
(Sep 30 2021)   (Sep 30 2012)



PACB Company Profile >> Back to PACB Efficiency Comparisons >> Compare PACB Inventory Turnover Ratio to its Competitors

Financial Statements
Pacific Biosciences Of California Inc 's Inventories $ 61 Millions Visit PACB's Balance sheet
Pacific Biosciences Of California Inc 's Cost of Revenues TTM $ 101 Millions Visit PACB's Income Statement
What are PACB's Sales? Visit PACB's Sales by Segment

Other Inventory Turnover Ratios
Pacific Biosciences Of California Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PACB's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PACB's Competitors
Inventory Turnover Ratio for PACB's Suppliers
Inventory Turnover Ratio for PACB's Customers

You may also want to know
PACB's Sales Growth Rates PACB's Pe Price to earnings ratio PACB's Receivables Turnover Ratio PACB's Stock Quote
PACB's Net Income Growth Rates PACB's Ps Price to Sales ratio PACB's Sales per Employee PACB's Asset Turnover Ratio
PACB's Net Margin PACB's Pb Price to Book ratio PACB's Financial Strength Ratios PACB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.